Background: Bordetella pertussis has been suggested to take part in the acute exacerbation of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the association between B. pertussis and COPD. Materials and Methods: In this case-control study, 90 patients with COPD and 90 age-and sex-matched control subjects were included. Serum samples were tested for anti-B. pertussis IgG and IgA by ELISA. A physician completed a questionnaire including demographic characteristics, habitual history and spirometric findings for each patient. Results: Of 90 patients with chronic obstructive pulmonary disease, 66 (51%) had mild, 31 (34.4%) had moderate, and 13 (14.4%) had severe disease. There was no significant association between B. pertussis IgA seropositivity and COPD. Serum levels of anti-B. pertussis IgG were significantly higher in patients with COPD than in the control subjects (P < 0.001). No association was observed between B. pertussis infection and severity of COPD.
INTRODUCTION
Pertussis or whooping cough is caused by Bordetella pertussis. Although its incidence has decreased following worldwide immunization, recent trends show the increasing incidence of pertussis among teenagers and adults (1) . Some studies indicate pertussis to be the cause in 20%-30% of patients suffering from chronic cough of more than 2 weeks duration (1, 2) . (6) (7) (8) . Based on these findings it seems appropriate to study the relationship between pertussis and COPD.
The aim of this study was to compare the seroprevalence of B. pertussis between COPD patients and control subjects, and to evaluate the association between B.
pertussis seropositivity and severity of COPD.
MATERIALS AND METHODS

Study design, patients and controls
In this case-control study, 90 consecutive patients with 
Ethical considerations
This study was approved by the Ethical Committee of Hamedan University of Medical Sciences, Hamedan, Iran and written informed consents were obtained of all participants.
Data Collection and measurements
After obtaining informed consent, a questionnaire including demographic characteristics, history of cigarette smoking, and pulmonary function test results was filled out for each subject, and a serum sample was obtained and stored at -20°C until use.
Antibody titers against pertussis toxin (anti-PT) were measured by ELISA using specific kits for anti-PT IgG and IgA (IBL, Homburg, Germany). Anti-PT IgG titers more than 24 U/mL and anti-PT IgA titers more than 12 U/mL were considered to be positive.
Statistical analysis
Data were analysed using SPSS statistical package version 15, and P < 0.05 was considered statistically significant. T-test was used for analysis of quantitative variables and chi-square test for qualitative variables.
RESULTS
Ninety patients with COPD (65 males and 25 females, mean age of 67.7 ± 1.2 years) and 90 age-and sex-matched control subjects (53 males and 37 females, mean age of 61.6 ± 1.2 years) were included in the study. According to the GOLD classification, 66 (51%) patients with COPD had mild, 31 (34.4%) had moderate, and 13 (14.4%) had severe disease. No patient was found to have very severe COPD. Table 1 shows the seroprevalence of B. pertussis infection in patients with COPD and control subjects.
There was no significant difference in anti-PT IgA seropositivity between the study and control groups (P= 0.448). The frequency of anti-PT IgG seropositivity was significantly higher in patients with COPD than in controls (P<0.001). The frequency of anti-PT IgA and anti-PT IgG seropositivity in different stages of COPD is shown in Table 2 . No significant association was found between the severity of COPD and the frequency of anti-PT IgA and anti-PT IgG seropositivity. It is well known that LPS induces tumor necrosis factor (TNF)-alpha. TNF-alpha overexpression in mice has been reported to cause some diverse effects, including pulmonary emphysema and pulmonary fibrosis (17, 18) .
Other researchers have reported that TNF-alpha plays a critical role in smoking-related emphysema. The high levels of TNF-alpha are found in the serum of smokers (19) .
Repeated releases of TNF-alpha may be related to the high concentrations of bacterial endotoxin in tobacco and bioactive LPS in cigarette smoke (20, 21) . Considering these findings, TNF-alpha is believed to play a major role in development of COPD. These toxins cause the inhibition of microphage function and survival of the bacteria (25, 26) . These characteristics of pertussis infection and its higher prevalence among adults in the recent years indicate a possibility for its involvement in the occurrence of COPD, which necessitates further research to evaluate its role in chronic respiratory diseases.
In conclusion, our findings indicate a correlation between pertussis and COPD. Considering the fact that our results are based on a serological case-control study, further investigations are necessary to calculate the relative risk of COPD in patients with a history of pertussis.
